The IQVIA Institute for Human Data Science

Evidence-based insights for healthcare

The IQVIA Institute for Human Data Science contributes to the advancement of human health globally through timely research, insightful analysis and scientific expertise applied to granular non-identified patient-level data.
Subscribe to the IQVIA Institute
Be among the first to hear about research and activities

View all of the IQVIA Institute's Upcoming and On-Demand Events

Explore the research and findings in our four annual trend reports

The Global Use of Medicines

Learn about spending and usage of medicines in the past year and outlook to the future, globally and across specific therapy areas and countries.

Global Trends in R&D

Discover trends in drug approvals and launches, pipeline activity, and data on clinical trial activity.

The Use of Medicines in the U.S.

Examine the state of the U.S. health system, medicine usage, drug pricing, and costs for patients.

Global Oncology Trends

Explore research and development in oncology and the progress being made to improve representativeness of race and ethnicity in clinical trial populations.

Global Trends in R&D 2023: Activity, Productivity, and Enablers

Hear IQVIA Institute Executive Director Murray Aitken discuss R&D activity through the end of 2022, including drug approvals, medicines in the pipeline, clinical trial activity, clinical development productivity, innovation, funding, and more.

The Global Use of Medicines 2023: Outlook to 2027

In this video, Murray Aitken offers a look at the past and future impact of COVID-19 on the use of medicines, the outlook for the use of medicines and key drivers of change, important therapy areas, and overall spending levels for all prescription drugs and key dynamics at a country, therapy, and product level – both historically and the outlook to 2027. 

Follow us on Twitter
Learn more about how the IQVIA Institute contributes to the advancement of human health.
Contact Us